Please Wait...

Technology for Clinical Trial Supply Planning

The 2010 Optimizer User Conference recently ended and I am happy to report a surge in discussion around technology for clinical trial supply planning. I think this speaks well to the growth of the Optimizer product and greater acceptance of the application of more sophisticated tools to the clinical supply planning process in general.

There were a number of roundtable discussions and open training sessions, which were as valuable for me as I believe they were for the attendees.

During one of the training sessions there was a lengthy discussion on the best practice for early clinical trial supply planning of variable dose or titration studies.  

These protocols present a unique challenge - early on there typically is not a lot of information available regarding how the subject population will respond to or tolerate certain doses. Typical Floor/Ceiling or Safety Stock resupply algorithms are very inefficient at managing these studies. The ability to add prediction of the variable dose visits to these protocols can be extremely effective at minimizing excess drug supply while ensuring the correct dose is available, at the right place, at the right time. Through automation, different resupply algorithms and settings can be modeled and simulated providing valuable information to the clinical trial supply planning process.

For example, what happens if I predict the existing subject dose plus the potential for one titration up, or what if I predict for all possible titrations, some or all of the time?

I welcome your thoughts and any discussion on clinical trial supply technology and best practices.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @SchulmanIRB: #FDA final rule requires #medicaldevice #research conducted outside US to conform with GCP standards | via @RAPSorg https:…
bioclinica (14 hours ago)
RT @manchempharma: Paul Brooks, Executive Director, @RAPSorg comments on Brexit and the operational trade and regulatory environment affect…
bioclinica (14 hours ago)
RT @eClinical_Jen: Clinical Data Management articles available on SCDM Website - While all articles are available to members, there are sel…
bioclinica (14 hours ago)
Live from Las Vegas where Bioclinica's Research Development Director Marieke Cajal, PhD, is presenting on site star… https://t.co/lVglg6NWdV
bioclinica (15 hours ago)
Many thanks all who attended @bioclinica's Executive Roundtable on Safety Mgmt for Pharma Cos in Japan in Tokyo th… https://t.co/OzHeSvHTUk
bioclinica (15 hours ago)
RT @bioclinica: @CardiacSafety Consortium needs your feedback! Help make the upcoming think tank "Evaluation of #MobileTechnologies in #CV…
bioclinica (17 hours ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen